Manulife-Sinochem

Manulife-Sinochem

Manulife-Sinochem Life Insurance launched in 1996 as China's first joint-venture life insurer, formed between Canada's Manulife Financial Corporation and China's Sinochem Holdings. The Shanghai-based carrier writes life, health, and accident policies across the mainland, and its investment arm channels general-account assets into alternatives. Manulife holds 51% and Sinochem 49%, a structure that has survived two decades of regulatory evolution in China's insurance market. General-account allocations span private equity, real estate, and infrastructure. The firm owns commercial real assets including its Jin Mao Tower headquarters and units in Beijing's Xicheng Jinmao Centre, while an elderly-care network across multiple Chinese cities signals a thematic bet on aging demographics that connects the liability side of its book with the asset side. The insurer also maintains a multiyear partnership with NBA China, building community courts as a brand and distribution play. Professional headcount is not disclosed. In February 2024, the firm elevated Xiaoyong Wu to CEO and General Manager, a transition that consolidates leadership under a longtime insider. Manulife-Sinochem participates in the Canada China Business Council, and Manulife's global CEO sits on Shanghai's International Business Leaders' Advisory Council — a signal of the political capital the firm maintains in its home market. What distinguishes this entity from pure-play Chinese insurers is its governance architecture: a foreign-majority JV that predates China's WTO accession-era insurance liberalization by years. The 51% Manulife stake gives the Canadian parent boardroom influence over underwriting and investment policy in a market where foreign insurers typically operate with 50% caps or less — a grandfathering advantage that shapes how capital is deployed across an otherwise domestically focused balance sheet.